These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20567190)

  • 1. Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial.
    Andelin CO; Drobnis EZ; Schust DJ
    Obstet Gynecol; 2010 Jul; 116(1):194-195. PubMed ID: 20567190
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
    Haaland RE; Holder A; Evans-Strickfaden T; Nyagol B; Makanga M; Oyaro B; Humwa F; Williams T; McLellan-Lemal E; Desai M; Huey MJ
    Contraception; 2017 Jun; 95(6):602-604. PubMed ID: 28372978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hormonal ring. A new contraceptive gains acceptance.
    Hardy EE; Reyes Q; Gomez F; Portes-carrasco R; Faundes A
    IDRC Rep; 1984 Jul; 13(2):11. PubMed ID: 12313242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials.
    Roumen FJ
    Contraception; 2007 Jun; 75(6):420-9. PubMed ID: 17519147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
    Gallo MF; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2003; (1):CD003552. PubMed ID: 12535478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with willingness to use the contraceptive vaginal ring.
    Gilliam M; Holmquist S; Berlin A
    Contraception; 2007 Jul; 76(1):30-4. PubMed ID: 17586133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.
    Nel A; Bekker LG; Bukusi E; HellstrÓ§m E; Kotze P; Louw C; Martinson F; Masenga G; Montgomery E; Ndaba N; van der Straten A; van Niekerk N; Woodsong C
    PLoS One; 2016; 11(3):e0147743. PubMed ID: 26963505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vaginal ring and transdermal patch: new methods of contraception.
    McNamee K
    Sex Health; 2006 Sep; 3(3):135-42. PubMed ID: 17044218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-use ring weight and residual drug content as potential objective measures of user adherence to a contraceptive progesterone vaginal ring.
    Murphy DJ; McCoy CF; Plagianos M; RamaRao S; Merkatz R; Clark H; Boyd P; Variano B; Malcolm RK
    Contraception; 2019 Sep; 100(3):241-246. PubMed ID: 31247194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial.
    Gilliam ML; Neustadt A; Kozloski M; Mistretta S; Tilmon S; Godfrey E
    Obstet Gynecol; 2010 Mar; 115(3):503-510. PubMed ID: 20177280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
    Lopez LM; Grimes DA; Gallo MF; Schulz KF
    Cochrane Database Syst Rev; 2010 Mar; (3):CD003552. PubMed ID: 20238323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hormonal ring: a new contraceptive gains acceptance.
    Asian Pac Popul Programme News; 1984 Dec; 13(4):39-40. PubMed ID: 12313703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the pill. Four new devices aim to make contraception easier.
    Brink S
    US News World Rep; 2002 Sep; 133(11):54, 56. PubMed ID: 12360832
    [No Abstract]   [Full Text] [Related]  

  • 14. The progestagen releasing vaginal ring.
    Elstein M; Nuttall ID
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S51-7. PubMed ID: 12268770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonspermicide fit-free diaphragm trial reported.
    Netw Res Triangle Park N C; 1984; 5(3):7. PubMed ID: 12279800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.
    Roumen FJ; Apter D; Mulders TM; Dieben TO
    Hum Reprod; 2001 Mar; 16(3):469-75. PubMed ID: 11228213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
    Dahiya P; Dalal M; Yadav A; Dahiya K; Jain S; Silan V
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():147-51. PubMed ID: 27285306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
    Lopez LM; Grimes DA; Gallo MF; Schulz KF
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003552. PubMed ID: 18254023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive vaginal ring.
    Madden T; Blumenthal P
    Clin Obstet Gynecol; 2007 Dec; 50(4):878-85. PubMed ID: 17982330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.